The Centers for Medicare and Medicaid Services criteria are used to flag high-risk patients for opioid abuse and overdose.
The center will unite researchers interested in using big data to evaluate drugs and the safety of medications in real-world populations.
The FDA awarded a $330,000 grant to Almut Winterstein, Ph.D., to lead the 18-month study.
The 2018 Pharmacy Practice Research Award was presented at the ASHP Midyear meeting in Anaheim.
As president-elect, Almut Winterstein will serve on the executive board and chair the strategic planning committee. She joined ISPE in 2000 and has held numerous leadership roles during the past two decades.
The researchers reviewed medical claims for around half million adults in 29 states who had used either azithromycin or amoxicillin during a 10 year period.
The study examines the prevalence and factors associated with the long-term concurrent use of stimulants and opioids among adults with ADHD.
Winterstein is one of four UF College of Pharmacy faculty members named as UF Term Professors.
The nearly $3 million grant will enhance the FDA’s capability to conduct drug safety studies on maternal and infant outcomes involving exposure to medications during pregnancy.
The paper authored by researchers in the department of pharmaceutical outcomes and policy won the University of Florida College of Pharmacy’s 2018 Best Clinical Research Paper Award.